BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34162508)

  • 1. The promoter aberrant methylation status of TMEM130 is associated with gastric cancer.
    Zhang Y; Hu S; Li J; Shi D; Luo B
    Dig Liver Dis; 2022 Jun; 54(6):819-825. PubMed ID: 34162508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation-mediated down-regulation of TMEM130 promotes cell migration in breast cancer.
    Liu H; Xie HQ; Zhao Y; Zhang W; Zhang Y
    Acta Histochem; 2021 Dec; 123(8):151814. PubMed ID: 34763116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMEM130 regulates cell migration through DNA methylation in nasopharyngeal carcinoma.
    Liu H; Zhang Y; Chen W; Zhang Y; Zhang W
    Cancer Biomark; 2022; 34(2):265-273. PubMed ID: 34958002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
    Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
    Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma.
    Osawa T; Chong JM; Sudo M; Sakuma K; Uozaki H; Shibahara J; Nagai H; Funata N; Fukayama M
    Jpn J Cancer Res; 2002 Nov; 93(11):1195-200. PubMed ID: 12460459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
    Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
    Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; zur Hausen A; Gabbert HE; Sarbia M
    Cell Oncol (Dordr); 2011 Jun; 34(3):209-14. PubMed ID: 21538028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Epstein-Barr Virus (EBV) Infected Gastric Cancer in Increasing microRNA124 (miR-124) Promoter Methylation and Enhancer of Zeste Homolog 2 (EZH2) Gene Expression.
    Ghoreshi ZA; Rezaei Zadeh Rukerd M; Askarpour H; Kheirkhah Vakilabad AA; Nakhaie M; Abbaszadeh Afshar MJ; Behboudi E; Charostad J; Arefinia N
    Medicine (Baltimore); 2024 Mar; 103(12):e36534. PubMed ID: 38517989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma.
    Liu X; Wang Y; Wang X; Sun Z; Li L; Tao Q; Luo B
    Arch Virol; 2013 Jan; 158(1):123-32. PubMed ID: 23001722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma.
    Choi SJ; Shin YS; Kang BW; Kim JG; Won KJ; Lieberman PM; Cho H; Kang H
    Arch Pharm Res; 2017 Aug; 40(8):894-905. PubMed ID: 28779374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.
    Kim J; Lee HS; Bae SI; Lee YM; Kim WH
    Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines.
    Li J; Liu X; Liu M; Che K; Luo B
    Dig Liver Dis; 2016 Jun; 48(6):673-80. PubMed ID: 27026080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
    Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
    Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Yang J; Liu Z; Zeng B; Hu G; Gan R
    Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
    Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
    Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylation and imprinting expression of Insulin-like growth factor 2 gene in gastric cancer.
    Sun J; Shu J; Shi D; Liu W; Zhang Y; Luo B
    Cancer Biomark; 2023; 38(3):355-366. PubMed ID: 37718779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
    Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
    Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.